ProGRP is known as a precursor of GRP and was proved to be more stable than GRP; former studies validated that alteration of ProGRP level could be a prognostic factor for clinical response, PFS, and OS of SCLC patients.[31] However, the role of ProGRP in distinguishing good and poor prognosis was not revealed in our study. This evidence concerns the gene GRP and small cell lung carcinoma.